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Abstract
High-throughput DNA sequencing approaches have enabled direct interrogation of chromatin
samples from mammalian cells. We are beginning to develop a genome-wide description of nuclear
function during development, but further data collection, refinement, and integration are needed.
Introduction and context
Until recently, the primary motivation for DNA sequen-
cing was a structural one. We wanted to sequence a
specific molecule, perhaps a genome, to ‘read‘ the
information encoded in the DNA sequence. Determina-
tion of new genome sequences is still a major activity,
and furthermore, sequencing of additional copies of the
same genome to identify variation has moved on apace.
However, the availability of extensive genome sequences
of the major model organisms, including human [1],
and the development of second-generation high-
throughput (HTP) methods and instrumentation for
genome sequencing [2,3] have opened up a new area of
application: use of DNA sequencing as an analytic
method. In this analytic mode, sequencing stands at
the evolutionary pinnacle of a line of methods stretching
back through DNA microarrays via Southern and North-
ern blotting to solution hybridisation. For any experi-
mental sample containing nucleic acids, we want to
determine the composition, preferably with accurate
quantitation. Whereas prior methods depended upon
nucleic acid hybridisation producing an analog signal
one-step removed from the sequence of the DNA
molecules, sequencing offers precise determination of
the composition of a nucleic acid mixture and is not
restricted to the sequences available on a microarray.
Moreover, for complex nucleic acid samples, HTP
sequencing generates gigabases of genome-wide
sequence from each instrument run, providing
quantitative digital information on an acceptable time-
scale at a cost that facilitates coverage for even large
genomes.
Over the past 2 years, a number of reports have
described the application of this new analytic approach
to a variety of chromatin sample mixtures derived from
mammalian cells. These data are beginning to give us a
description of the complex regulatory processes that
control the function of the genome in the cell nucleus.
Major recent advances
Johnson et al. [4] described the application of HTP
sequencing to chromatin immunoprecipitated with
antibody to human neuron-restrictive silencer factor
(NRSF) in the Jurkat T-cell line [chromatin-immunopre-
cipitation sequencing (ChIP-seq)]. They identified 1,946
NRSF-binding sites associated with repression of gene
transcription close to 1,020 genes. These included
previously unidentified gene targets of NRSF repression.
In addition, a significant number of NRSF sites contain-
ing a relaxed form of the previously identified canonical
NRSF-binding motif were identified. Concurrently,
Robertson et al. [5] used ChIP-seq to identify ~41,000
and ~11,000 potential STAT1 targets in human HeLa S3
cells with or without g-interferon stimulation respec-
tively, reflecting activation of STAT1 upon cytokine
stimulation. Sensitivity relative to known STAT1 targets
was determined as 71%. Notably, Robertson et al.
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reads than Johnson et al. In both studies, approximately
one-half to two-thirds of the total sequences generated
could be mapped uniquely to the genome. The success of
both studies indicated that ChIP-seq using antibodies for
transcription factors (TFs) could be deployed to create
genome-wide maps of TF-binding sites. Future mapping
of many TFs on samples from multiple tissues will result
in a rich map of regulatory sites across the genome.
An alternative approach to mapping regulatory sites,
including promoters, enhancers, silencers, and insula-
tors, is to identify sites of DNase 1 hypersensitivity. HTP
sequencing of libraries from DNase 1-digested nuclei of
primary human CD4
+ T-cells was used by Boyle et al. [6],
together with microarray data, to define ~95,000 sites on
a genome-wide DNase 1 hypersensitivity map. Many of
the strongest DNase 1 sites are found at transcription
start sites (TSSs), but this accounts for only 16% of sites,
whereas only 15.5% of sites lie outside of genes. Virtually
all of the TSSs of highly expressed genes are marked by
DNase 1 hypersensitive sites (HSs). Strikingly, Boyle et al.
found that background DNase 1 sensitivity away from
HSs exhibited an oscillating pattern occurring over a
single nucleosome length with a frequency of one DNA
double-helical turn. Furthermore, well-positioned
nucleosomes could be detected close to some HSs.
DNase 1 HS maps will serve as a valuable backbone on
which to overlay TF-binding sites identified by ChIP-seq.
ChIP-seq has also been applied to analysis of the
distributions of modified histones across the genome.
Barski et al. [7] analysed enrichment of 20 different
histone methylations as well as RNA polymerase II,
CCCTC-binding factor (CTCF), and the histone variant
H2AZ in CD4
+ T-cells. In addition to the previously
described association of histone H3K4me1, H3K4me2,
H3K4me3, and H3K36me3 association with gene
activation, histone H3K27, H3K9, H4K20, H3K79, and
H2BK5 monomethylations were all linked to active
genes. In contrast, histone H3K27 and H3K9 trimethyla-
tions were associated with repressed genes and hetero-
chromatin formation. CTCF was found to mark the
boundaries of active and repressed histone modification
domains [8]. Since the Barski et al. ChIP-seq protocol
used micrococcal nuclease digestion to prepare mono-
nucleosomes, the sequence data could be analysed on a
strand-specific basis to identify nucleosome positions in
promoters with extremely fine resolution [9]. Further
analysis of additional histone methylations and acetyla-
tions in CD4
+ T-cells indicated that many of the
modifications are strongly correlated [10]. For instance,
a module including 17 histone modifications appears to
be common at promoters. Mikkelsen et al. [11] also
generated genome-wide maps of chromatin modifica-
tions in embryonic stem and lineage-committed cells
and observed that actively transcribed genes are marked
by H3K4me3 at their promoters and H3K36me3 along
their transcribed length. H3K27me3 marked either
regions that are transcriptionally repressed or, when
H3K27me3 occurred together with H3K4me3 at a
promoter, genes poised for expression along future
developmental paths. Subsequently, the H3K4me3/
H3K36me3 signal at actively transcribed genes has
been used to identify novel multi-exonic non-coding
RNA genes [12]. A further advantage of the sequencing
approach was revealed by Mikkelsen et al., who were able
to identify allele-specific histone modification patterns
using single-nucleotide polymorphisms.
Future directions
The application of HTP sequencing in ChIP-seq and
DNase 1-seq is now extending to other TFs and other
cells and tissues. The next step will be to integrate the
different datasets with each other and with other
approaches using HTP sequencing including DNA
methylation analysis [13] and sequencing of cellular
transcriptomes [14,15] to provide a comprehensive view
of the regulation of transcription at a chromatin-wide
level. Further on, it may be possible, along with HTP data
on the three-dimensional interactions within chromatin
[16], to model the regulatory structure of the nucleus.
Comparison of these comprehensive chromatin-state
maps between tissues and along developmental path-
ways should facilitate our understanding of regulation in
development and disease.
The application of HTP sequencing to these complex
samples is not without its caveats. Substantial algorith-
mic development to map the sequence reads efficiently
and to score the sites of enrichment compared with an
untreated control (non-immunoprecipitated chromatin
or ‘input’ for ChIP-seq) is still ongoing. Indeed, even for
the most comprehensively sequenced genome, not all
sequences are represented in the reference, including
unknown amounts of certain repetitive sequences,
therefore careful filtering of the data is required.
Improvements in the sequencing technologies, including
higher throughput and longer sequence reads, will help
to address these issues as well as to increase productivity
and cost efficiency. However, sample input for ChIP-seq
is also limited by the availability of suitable antibodies.
In addition, future technologies that sequence single
molecules without amplification may allow certain
applications to work with very few cells, thereby over-
coming the limitation restricting current analyses to the
averages of broad populations of cells. In any case, it is
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be located in every functional genomics laboratory.
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